We conducted a prospective , randomized , double-blind , placebo-controlled study of CMV infected persons with AIDS with either CD4 + lymphocyte counts of < or = 50 per cubic millimeter or counts of < or = 100 per cubic millimeter in those with a history of an AIDS defining opportunistic infection .
